BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 13/04/2026

FDA Clears BILTRICIDE Oral Tablet for Sale

The FDA has determined that BILTRICIDE oral tablet, 600mg, was not withdrawn from sale due to safety or effectiveness concerns, allowing it to continue being approved for use in ANDAs.

Source: Federal Register — Food and Drug AdministrationOpen original release →